Whitepaper: Detecting CAR-T cells using Fluorokines™

This article outlines the advantages of using R&D Systems™ fluorescent-labeled proteins to directly stain and detect CAR+ cells by flow cytometry.

One of the current challenges in the field of CAR-T cell therapy is the lack of a simple assay to easily detect and quantify chimeric antigen receptor (CAR) expression following T cell transduction. Read this whitepaper to learn about the advantages of using R&D Systems™ fluorescent-labeled proteins to directly stain and detect CAR+ cells by flow cytometry. Data is presented showing that Fluorokines are compatible with antibody panels for characterizing CAR-T cells by multi-colour flow cytometry.

READ NOW